These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of mind on brain activity: evidence from neuroimaging studies of psychotherapy and placebo effect. Beauregard M Nord J Psychiatry; 2009; 63(1):5-16. PubMed ID: 19023697 [TBL] [Abstract][Full Text] [Related]
23. Cognitive function in acute hypoglycaemia 2. Bingham E; Rosenthal JM; Amiel SA Diabetes Nutr Metab; 2002 Oct; 15(5):363-7. PubMed ID: 12625485 [No Abstract] [Full Text] [Related]
24. [Parkinson syndrome and cognitive disorders]. Szirmai I; Kovács T Ideggyogy Sz; 2002 Jul; 55(7-8):220-5. PubMed ID: 12201229 [TBL] [Abstract][Full Text] [Related]
25. [Noninvasive functional measurement of human memory and recognition system]. Watanabe E Tanpakushitsu Kakusan Koso; 1995 Apr; 40(6):855-62. PubMed ID: 7754071 [No Abstract] [Full Text] [Related]
26. Basal ganglia function and dysfunction revealed by PET activation studies. Ceballos-Baumann AO; Brooks DJ Adv Neurol; 1997; 74():127-39. PubMed ID: 9348408 [No Abstract] [Full Text] [Related]
30. Genetic characterization of cognitive impairment in Parkinson's disease. Dujardin K; Devos D Brain; 2014 Oct; 137(Pt 10):2630-1. PubMed ID: 25217791 [No Abstract] [Full Text] [Related]
31. Does a long preclinical period occur in Parkinson's disease? Koller WC; Langston JW; Hubble JP; Irwin I; Zack M; Golbe L; Forno L; Ellenberg J; Kurland L; Ruttenber AJ Geriatrics; 1991 Aug; 46 Suppl 1():8-15. PubMed ID: 1894149 [No Abstract] [Full Text] [Related]
32. Does a long preclinical period occur in Parkinson's disease? Koller WC; Langston JW; Hubble JP; Irwin I; Zack M; Golbe L; Forno L; Ellenberg J; Kurland L; Ruttenber AJ Neurology; 1991 May; 41(5 Suppl 2):8-13. PubMed ID: 2041599 [No Abstract] [Full Text] [Related]
33. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects. Bötzel K; Schulze S Brain; 1996 Jun; 119 ( Pt 3)():1045-8. PubMed ID: 8673482 [No Abstract] [Full Text] [Related]
34. Seeing the mind. Posner MI Science; 1993 Oct; 262(5134):673-4. PubMed ID: 8235585 [No Abstract] [Full Text] [Related]
35. Subjectively speaking: a patient's view of Parkinson's disease. Bernen R R I Med J (1976); 1986 Jul; 69(7):313-7. PubMed ID: 3462888 [No Abstract] [Full Text] [Related]
36. Depression in Parkinson's disease: a biochemical and organic viewpoint. Mayberg HS; Solomon DH Adv Neurol; 1995; 65():49-60. PubMed ID: 7872152 [No Abstract] [Full Text] [Related]
37. Neural modeling and functional brain imaging: an overview. Horwitz B; Friston KJ; Taylor JG Neural Netw; 2000; 13(8-9):829-46. PubMed ID: 11156195 [TBL] [Abstract][Full Text] [Related]
38. [Joint PET and electrophysiological research on human thinking activity]. Bekhtereva NP; Medvedev SV; Abdullaev IaG; Kostenikov NA; Nechaev VB; Rudas MS; Vorob'ev VA Zh Vyssh Nerv Deiat Im I P Pavlova; 1994; 44(3):431-40. PubMed ID: 7941706 [TBL] [Abstract][Full Text] [Related]
39. Lexical decision in Parkinson's disease: a reply to Brown, McDonald, and Spicer (1999). Arnott WL; Chenery HJ J Clin Exp Neuropsychol; 2001 Apr; 23(2):250-1. PubMed ID: 11370639 [No Abstract] [Full Text] [Related]
40. [Methods of diagnosis early stage Parkinson's disease]. Katunina EA; Titova NV; Avakian GN Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):112-8. PubMed ID: 21434466 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]